CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 120 enrolled
Drug / intervention
Retzius sparing radical prostatectomy +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02352103
NCT02352103Phase 3Completed

The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial

Henry Ford Health System·interventional·Posted Feb 2, 2015·Updated Feb 25, 2022

In Brief

A Phase 3 clinical trial evaluating Retzius sparing radical prostatectomy, Vattikuti Urology Institute radical prostatectomy, and 1 other intervention for Urinary Incontinence. Completed, enrolled 120 participants across 2 sites.

Detailed Summary

To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2, 2015
Enrollment StartJan 1, 2015
Primary CompletionApr 1, 2016
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.4 years ago

Interventions

Retzius sparing radical prostatectomyprocedure

Robotic assisted laparoscopic radical prostatectomy based on Retzius sparing technique

Vattikuti Urology Institute radical prostatectomyprocedure

Robotic assisted laparoscopic radical prostatectomy based on Vattikuti Urology Institute technique

da Vinci Surgical Systemdevice

The da Vinci Surgical System is a sophisticated robotic platform designed to expand the surgeon's capabilities and offer a state-of-the-art minimally invasive option for major surgery.